Years after ALLHAT, alpha-blocker use common, risky. IN Your dose of medicine [column]

Years after ALLHAT, alpha-blocker use common, risky. IN Your dose of medicine [column]

Bibliografski detalji
Izdano u:Philippine Star Vol. 34, no. 183 (26 Jan. 2020), 9
Glavni autor: Chante, Charles C.
Format: Članak
Izdano: 2020
Teme:
Heart diseases
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Heart failure